Eric K Nakakura
Overview
Explore the profile of Eric K Nakakura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
2279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Mahuron K, Kasai Y, Javeed Z, Bergsland E, Hirose K, Corvera C, et al.
J Gastrointest Surg
. 2021 Mar;
25(11):2954-2956.
PMID: 33742361
No abstract available.
22.
Gomez A, Wisneski A, Luu H, Hirose K, Roberts J, Hirose R, et al.
J Gastrointest Surg
. 2020 Oct;
25(1):77-84.
PMID: 33083858
Background: Hepatic cyst disease is often asymptomatic, but treatment is warranted if patients experience symptoms. We describe our management approach to these patients and review the technical nuances of the...
23.
Wisneski A, Jin C, Huang C, Warren R, Hirose K, Nakakura E, et al.
J Surg Res
. 2020 Aug;
256:476-485.
PMID: 32798995
Background: Synchronous colorectal cancer liver metastasis (CRLM) has been viewed as being more aggressive and having shorter survival than metachronous disease. Advances in CRLM management led us to examine differences...
24.
25.
Kasai Y, Nakakura E
Surg Case Rep
. 2020 May;
6(1):110.
PMID: 32448968
Omori et al. reported a case of multiple liver metastases originating from synchronous double cancer of "primary mesenteric neuroendocrine tumor" and rectal cancer. However, the "primary mesenteric neuroendocrine tumor" might...
26.
Wisneski A, Carter J, Nakakura E, Posselt A, Rogers S, Cello J, et al.
HPB (Oxford)
. 2020 Apr;
22(10):1496-1503.
PMID: 32340857
Background: Ampullary stenosis following Roux-en-Y gastric bypass (RYGB) is increasingly encountered. We describe cases of biliary obstruction from ampullary stenosis and choledocholithiasis to illustrate the associated diagnostic and interventional challenges...
27.
Kasai Y, Mahuron K, Hirose K, Corvera C, Kim G, Hope T, et al.
J Surg Oncol
. 2020 Apr;
122(2):204-211.
PMID: 32291778
Background And Objectives: We classified the extent of mesenteric mass (MM) involvement that predicts challenging mesenteric lymph node dissection (mLND) by minimally invasive surgery (MIS) for ileal neuroendocrine tumors (i-NETs)....
28.
Kramer S, Bowman C, Wang Z, Sheahon K, Nakakura E, Cho S, et al.
J Gastrointest Cancer
. 2020 Feb;
51(3):1025-1029.
PMID: 32034641
No abstract available.
29.
Kasai Y, Hirose K, Corvera C, Kim G, Hope T, Shih B, et al.
J Surg Oncol
. 2019 Dec;
121(2):330-336.
PMID: 31828813
Background And Objectives: We developed objective measurements of preoperative and residual tumor volume, and debulking rate, to evaluate their prognostic value for neuroendocrine liver metastasis (NELM). Methods: Seventy-three patients who...
30.
Kasai Y, Mahuron K, Hirose K, Corvera C, Kim G, Hope T, et al.
J Surg Oncol
. 2019 Oct;
120(8):1311-1317.
PMID: 31613999
Background And Objectives: Ileal neuroendocrine tumors (i-NETs) frequently metastasize to mesenteric lymph nodes and the liver. Regional lymphadenopathy is associated with desmoplasia of the mesentery forming a large mesenteric mass...